Live Cell Imaging Market 2028 By Product, Technology, Application, End User and geography | The Insight Partners

report image

Live Cell Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ( Equipment, Kits and Reagents, Software, Consumables ); Technology ( Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-content Analysis, Fluorescence In Situ Hybridization, Others ); Application ( Drug Discovery, Cell Biology, Developmental Biology, Stem Cells, Others ); End User ( Pharmaceutical and Biotechnology Companies, Hospitals, Diagnostic Laboratories, Others ) and geography

Report Code: TIPHE100001215 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. This method is used by the scientists to obtain a better view of the cell's biological function by studying the cellular dynamics. In recent years, live cell imaging technology has been widely accepted by various researchers to obtain a better knowledge regarding cell biology. Live cell imaging plays a crucial role in research fields such as neurology, immunology, microbiology and, genetics among others.


The "Global Live Cell Imaging Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the live cell imaging market with detailed market segmentation by product, technology, application, end user, and geography. The report provides key statistics on the market status of the leading live cell imaging market players and offers key trends and opportunities in the market.


  • Based on product, the global live cell imaging market is segmented into equipment, kits and reagents, software, consumables.
  • On the basis of technology, the market is segmented into fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high-content analysis, fluorescence in situ hybridization, and others.
  • Based on application, the market is bifurcated into Drug Discovery, Cell Biology, Developmental Biology,, Stem Cells, Others.
  • Based on end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and others.



  • Rising number of government funds for research and development activities.
  • Increasing number of cancer cases worldwide
  • Increasing adoption of biotechnology-based personalized medicine.


  • Under-developed research sector in a few developing countries


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The live cell imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the live cell imaging market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the live cell imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from live cell imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for live cell imaging in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the live cell imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • General Electric
  • Olympus Corporation
  • BioTek Instruments, Inc.
  • Molecular Devices, LLC.
  • Bruker
  • Nikon Instruments Inc.
  • Merck KGaA

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

The List of Companies

1. Thermo Fisher Scientific Inc.
2. PerkinElmer Inc.
3. General Electric
4. Olympus Corporation
5. BioTek Instruments, Inc.
6. Molecular Devices, LLC.
8. Bruker
9. Nikon Instruments Inc.
10. Merck KGaA
11. Keyence Corporation
12. NanoLive SA
13. Sony Biotechnology Inc.
14. Phase Focus
15. Logos Biosystems (Aligned Genetics, Inc.)

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount